Kesimpta Pre-filled pen for multiple sclerosis

Kesimpta Pre-filled pen for multiple sclerosis

If No prescription is available, book an appointment with our GP to issue a prescription

Kesimpta for multiple sclerosis (ofatumumab) “Monthly MS treatment, cared for end to end”

A once-monthly injection for adults with relapsing multiple sclerosis (MS), used at home with a pre-filled pen.

  • 20 mg per injection
  • 1x / month after 3 weekly starting doses
  • Store at 2- 8 °C in the fridge
  • 7 days max out of fridge, not above 30°C

For education only. Your doctor decides if Kesimpta is right for you. Always follow the leaflet in your pack.

How well Kesimpta works

In the ASCLEPIOS I and II trials, 1,882 adults with relapsing MS took Kesimpta or teriflunomide (an oral MS medicine) for up to 30 months.[3] Study 1 / Study 2:

  • 51% / 58% fewer relapses per year
  • 98% / 94% fewer active MRI lesions
  • 82% / 85% fewer new or enlarging T2 lesions
  • 34% lower risk of disability worsening

Kesimpta for multiple sclerosis at a glance

Kesimpta (ofatumumab) is a prescription B-cell therapy made by Novartis for adults with relapsing multiple sclerosis (MS). It is a 20 mg injection under the skin, given at weeks 0, 1 and 2 and then once a month, using a pre-filled pen at home. It is approved in the UAE.

Used for Adults with relapsing forms of MS: clinically isolated syndrome, relapsing-remitting MS and active secondary progressive MS ²
Generic name ofatumumab
Medicine type Human monoclonal antibody that targets CD20 (B-cell therapy)²
How it works Binds to CD20 on B cells and breaks them down. The exact way it works in MS is not known.²
Form 20 mg/0.4 mL single-dose pre-filled pen or syringe¹
How often Weeks 0, 1 and 2, then once a month from week 4¹
Not approved for Primary progressive MS, or anyone under 18²
Made by Novartis²
Status in the UAE Approved in the UAE. Prescription only.¹ᐟ⁷

Kesimpta delivery and support across the UAE

Al Thiqa delivers Kesimpta free across the UAE in cold-chain packaging, and supports you between doses with reminders, insurance approvals, and a pharmacist available 24/7.

  • Free delivery: Cold-chain, to your door
  • 24/7 pharmacist access: A clinical pharmacist, any time
  • Dose reminders: Before every monthly dose
  • Care coordination: We book your doctor visits
  • Side-effect support: Advice when you need it
  • Lab tests: Special rates on monitoring tests
  • Home injection support: Additional fee
  • Financial assistance: Where available

Kesimpta dosing schedule

Kesimpta is 20 mg injected under the skin: three starting doses at weeks 0, 1, and 2, no dose at week 3, then one dose every month from week 4.

  • Week 0 – starting dose
  • Week 1 – starting dose
  • Week 2 – starting dose
  • Week 3 – no dose
  • Week 4 – first monthly dose
  • Then – every month

The plan

  • 20 mg under the skin each time.¹
  • First injection under the guidance of a healthcare professional, then at home.²

Missed a dose?

  • Starting dose (week 0, 1 or 2): talk to your doctor.
  • Monthly dose: inject it as soon as possible. Do not wait for the next scheduled dose.
  • After that, keep injections a month apart.²ᐟ⁵

How to use the Kesimpta Sensoready pen

  1. Take out of the fridge 15 to 30 min before.
  2. Liquid should be clear to slightly opalescent. Do not use if cloudy or has particles.
  3. Use within 5 min of removing the cap. Press firmly. You will hear 2 clicks. Hold until the green indicator fills the window and stops moving.
  4. Into a sharps container right away. Never in household trash.

Steps from the official Instructions for Use.² If the green indicator does not fill the window, the medicine has not been delivered: contact your healthcare provider.

Where to inject Kesimpta

Inject Kesimpta into the front of the thigh or the lower belly. Use the outer upper arm only if a caregiver or healthcare professional injects for you.

  • 🟢 Front of thigh: the recommended site.
  • 🟢 Lower belly: not within 2 inches (5 cm) of the navel.
  • 🟣 Outer upper arm*: only if a caregiver or professional injects.
  • 🔴 Avoid tender, bruised, red, scaly, or hard skin, moles, scars, and stretch marks.²

Before you start Kesimpta for multiple sclerosis

Before the first dose, you need blood tests for hepatitis B, immunoglobulins, and liver function. Live vaccines should be given at least 4 weeks before you start.

Tests and vaccines

  • Hepatitis B, immunoglobulin, and liver tests.²
  • Live vaccines at least 4 weeks before. Non-live at least 2 weeks before, when possible.¹
  • Active infection? Treatment is delayed until it clears.²ᐟ⁶
  • Tell your doctor about immune medicines, liver problems, recent vaccines, pregnancy plans, or breastfeeding.

Do not use if you have

  • Active hepatitis B.
  • Had an allergy to ofatumumab, or a life-threatening reaction to a Kesimpta injection.²

First-dose checklist

Kesimpta: before your first dose

  • [ ] Blood tests done
  • [ ] Vaccines checked with my doctor
  • [ ] Insurance approval received
  • [ ] Fridge space ready (2-8°C) and sharps container
  • [ ] First injection booked
  • [ ] Monthly reminder set

How to store Kesimpta in UAE heat

Store Kesimpta in the fridge at 2-8°C. It can stay out of the fridge for up to 7 days, but never above 30°C, a temperature UAE cars and balconies pass quickly in summer.

  • In the fridge (2-8°C)
  • Original box, away from light
  • Do not freeze
  • Do not shake

Out of the fridge

  • Up to 7 days at room temperature, not above 30°C. Write the date on the box.
  • If unused, return it to the fridge and use it within 7 days, or discard.²
  • Pharmacist tip: in UAE heat, carry it in a cool bag and never leave it in a car.

Kesimpta side effects and when to call

The most common side effects of Kesimpta are colds, headache, flu-like reactions after injecting, and redness or pain where you inject.

Common

  • Colds and other upper respiratory infections
  • Headache
  • Fever, chills, muscle pain or tiredness after injecting, mostly with the first dose and within 24 hours
  • Redness, swelling, itching or pain where you inject¹

Call 998 for

  • Trouble breathing, chest tightness, feeling faint, or swelling of the face, eyelids, lips, tongue, or throat.

 Call your doctor for

  • Infection: fever, chills, cough, sore throat, runny nose, body aches, or painful and frequent urination.
  • Liver or hepatitis B: yellow skin or eyes, dark urine, nausea, vomiting, or feeling tired or weak.
  • Nerve changes: weakness on one side of the body, loss of coordination, vision problems, or changes in thinking, memory or personality.²

Kesimpta in pregnancy and breastfeeding

  • May lower B cells in an unborn baby.
  • Use effective birth control during treatment and for 6 months after the last dose.¹
  • Became pregnant? Tell your doctor right away. Breastfeeding or planning to? Talk to your doctor first.²

Sources

Last reviewed 18/11/2026

  1. Novartis. Kesimpta (ofatumumab) 20 mg Basic Succinct Statement, Version 2.1, effective 09-Aug-2023 (leaflet date Feb 2024). Published on the Novartis UAE healthcare professional site. Link
  2. Novartis. KESIMPTA US Prescribing Information, Medication Guide and Instructions for Use. Revised 4/2026 (current version). U.S. FDA. Link
  3. Hauser SL, Bar-Or A, Cohen JA, et al. Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med. 2020;383(6):546-557. doi:10.1056/NEJMoa1917246
  4. US Prescribing Information: OCREVUS (Genentech, revised 5/2026) Link; OCREVUS ZUNOVO (Genentech, revised 9/2026) Link; BRIUMVI (TG Therapeutics, revised 1/2026) Link
  5. Novartis. KESIMPTA patient website: Frequently Asked Questions. Link
  6. Novartis Pharmaceuticals UK. Kesimpta 20 mg pre-filled pen, Summary of Product Characteristics. Revised 24 September 2026. Link
  7. Novartis. Media release: EU approval of Kesimpta, 30 March 2021 (lists approval in the United Arab Emirates). Link
  8. Pardo G, Montalban X, Cohen J, et al. Ofatumumab treatment up to 8 years shows a favorable and consistent safety profile in people living with relapsing multiple sclerosis. American Academy of Neurology Annual Meeting, April 2026. Reported by NeurologyLive. Link

OTHER SIMILAR PRODUCTS